Literature DB >> 164580

[Carcinofetal antigens. I. alpha-fetoprotein (author's transl)].

R Lamerz, A Fateh-Moghadam.   

Abstract

Alpha-fetoprotein (AFP) is an alpha1-glycoprotein (M.W. about 65000) appearing in the fetal serum of most mammals including man during the early stages of pregnancy; 4 weeks after birth it disappears altogether or exists at very low concentrations as in the normal adult. AFP is formed in the yolk sac, the fetal liver and the gastro-intestinal tract. One of its physiological functions in fetal life is supposed to be the protection of the fetus from maternal oestrogens (oestrophilic property). The clinical significance of AFP is based on the regular and increasing production in primary liver cell carcinoma, less frequently in teratogenetic tumors where it serves as a control of therapy and course of the disease. Less frequent, minor and temporary increases in the AFP serum level occur in several primary tumors with secondary liver involvement, and in inflammatory gastro-intestinal diseases, e.g. of the liver (hepatitis, cirrhosis). AFP has an increasing importance in gynecology (gestational age, fetal distress syndrom, malformations, hydatidiform mole/chorion carcinoma). The physico-chemical properties of AFP are widely known. Both fetal and tumor AFP appear to be immunologically and biochemically identical, as are that of tissue and biological fluids. The differences observed (variants, microheterogeneity) depend mainly on the different content of sialic acid. An antigenetic relationship exists, between the AFP of most species. The immunodiffusion (Ouchterlony) is the most frequently used but relatively insensitive test (1-5 mug/ml) in finding AFP, whereas the radioimmunoassay is the most sensitive one (up to 0,25 ng/ml) and permits the determination of normal serum levels in adults (below 20 ng/ml). The serum concentration in healthy pregnant women lies up to 500 ng/ml, in patients with hepatitis, liver cirrhosis and other liver diseases mostly under 3 mug/ml, whereas in those with primary liver cell carcinoma levels up to and above 600 mg-percent have been found.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164580     DOI: 10.1007/bf01466760

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  367 in total

1.  Serum alpha-fetoprotein and resection of primary hepatic cancer.

Authors:  K Sugahara; A Kashii; H Kogure; J Manaka; T Shirakura; S Mitani
Journal:  Arch Surg       Date:  1973-01

2.  Autoradiographic localization of intracellular alpha-foetoprotein in primary liver cancer in man.

Authors:  J Uriel; F Loisillier; A M Szekely; H Bismuth
Journal:  Biomedicine       Date:  1974-01-20

3.  Amniotic-fluid alpha-fetoprotein in the antenatal diagnosis of spina bifida.

Authors:  L D Allan; M A Ferguson-Smith; I Donald; E M Sweet; A A Gibson
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

4.  Sites of alpha-fetoprotein synthesis.

Authors:  D Gitlin
Journal:  N Engl J Med       Date:  1971-12-16       Impact factor: 91.245

5.  In vitro synthesis of the foetal alpha 1-globulin in man.

Authors:  R Van Furth; M Adinolfi
Journal:  Nature       Date:  1969-06-28       Impact factor: 49.962

6.  Alpha fetoprotein in uterine hemorrhage during pregnancy and delivery.

Authors:  M Seppälä; I Aho; O Widholm; E Ruoslahti
Journal:  Am J Obstet Gynecol       Date:  1972-06-01       Impact factor: 8.661

7.  [Study on human fetal antigens. I. Immunoelectrophoretic study of antigens present in human fetal serum and absent from adult serum].

Authors:  P Burtin; S von Kleist; D Buffe
Journal:  Bull Soc Chim Biol (Paris)       Date:  1967-11-10

8.  [Importance of the proof of alpha 1-fetoprotein in the framework of pediatric tumor diagnosis].

Authors:  M Neidhardt; P Burtin; D Buffe
Journal:  Klin Wochenschr       Date:  1970-10-15

9.  Studies of a foeto-specific protein in rabbits. Absence of its relation to the human alpha-foetoprotein.

Authors:  M Seppälä; I J Seppälä
Journal:  Ann Chir Gynaecol Fenn       Date:  1969

10.  Occurrence of a specific foetal protein in a primary liver carcinoma.

Authors:  K Kithier; J Houstĕk; J Masopust; J Rádl
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

View more
  5 in total

1.  Fetal cells in the maternal circulation: detection by direct AFP-immunofluorescence.

Authors:  A Kulozik; I H Pawlowitzki
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

2.  [Immunohistochemical and radioimmunological demonstration of alpha1-fetoprotein in nonmalignant changes of human gastric mucosa (author's transl)].

Authors:  N Falser; B Lederer; H Reissigl
Journal:  Klin Wochenschr       Date:  1977-07-01

3.  The possible role of the carcinoembryonic antigen (CEA) and other carcinofetal antigens in maligant and benign diseases of the gastrointestinal tract.

Authors:  S von Kleist
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-10

4.  Human chorionic gonadotropin (HCG) in monitoring the course of testicular tumours.

Authors:  K Höffken; C G Schmidt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-09-24

5.  Excretion of alpha-foetoprotein in the urine of rats during exposure to 3'-methyl-4-dimethylaminoazobenzene.

Authors:  J H Boss; G Zajicek; E Okon; E Rosenmann
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.